Through continuous improvement in the field of containment and risk management, ability to scale-up and manufacture highly potent chemical intermediates and APIs (HPAPIs) continues to improve in the pharmaceutical industry. A well-established safety management system for HPAPIs can lead to increased flexibility in manufacturing and R&D capabilities.   A robust safety management of HPAPIs is … Continue reading Handling HPAPIs for maximum manufacturing flexibility while maintaining adequate safety controls